Erica Kahn and Jeff Rense: Un-Vaxed Showing DEADLY Clots, Shedding Signs After Simply Being Near The Vaxed

Jeff Rense and Erica Kahn discuss accumulating anecdotal evidence that the vaccinated are transmitting something to the unvaccinated as well as signs of deadly clots.

One example is of someone given chest compression 5 days after the vaccination resulting in blood coming out of every orifice. The doctor's response: "this couldn't have anything to do with the vaccine."

Un-Vaxed Showing DEADLY Clots, Shedding Signs After Simply Being Near The Vaxed - DANGER 

https://rense.com/general96/un-vaxed-showing-toxic-sheddings.php

Micro Clots Literally Creating 'Stiff' Hearts At Death

https://rense.com/general96/stiff-hearts.php

Death By Clot - Chest Compression Bleed Out Horror

https://rense.com/general96/death-by-clot.php

Dr. Charles Hoffe - Patients Showing Micro-Clots Within ONE WEEK Of Receiving Kill Shots - Watch

Patents Prove SARS Cov-2 Is A Manufactured Virus

Jeff & Erica Khan - Cutting Edge Data On Radioactive Isotopes And Resulting RadiationDamage To The Vaxed, 5 Doctors Excerpt...Tenpenny Has Earned A Vacation 

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England

NHS England

Published date: 22 July 2021

Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contrac

Contract summary

Industry

• Pharmaceutical products - 33600000

• Various medicinal products - 33690000

Location of contract

England

Value of contract

£3,185,000,000

Procurement reference

CF-0272200D0O000000rwimUAA1

Published date

22 July 2021

Closing date

3 September 2021

Closing time

1pm

Contract start date

1 November 2021

Contract end date

31 March 2024

Contract type

Supply contract

Procedure type

Open procedure (OJEU)

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).

Period of Framework: 01/11/2021 - 31/04/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 41 months)

All documents can be found at https://health.atamis.co.uk/. Atamis Reference Number: C40079